First drug approved for severe Alzheimer's


Clinicians will soon be able to treat patients with advanced Alzheimer?s disease (AD) using the first drug approved for use in the later stages of this progressive condition. The FDA recently approved memantine (Namenda, Forest Laboratories) for the treatment of moderate to severe AD. The drug will be available in pharmacies January.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.